Combination angiotensin-receptor blocker (ARB)/calcium channel blocker with HCTZ vs the maximal recommended dose of an ARB with HCTZ in patients with stage 2 hypertension: the exforge as compared to losartan treatment in stage 2 systolic hypertension (EXALT) study. [electronic resource]
Producer: 20120119Description: 588-97 p. digitalISSN:- 1751-7176
- Amlodipine -- adverse effects
- Angiotensin Receptor Antagonists -- adverse effects
- Blood Pressure -- drug effects
- Calcium Channel Blockers -- adverse effects
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Humans
- Hydrochlorothiazide -- adverse effects
- Hypertension -- drug therapy
- Losartan -- adverse effects
- Male
- Middle Aged
- Severity of Illness Index
- Tetrazoles -- adverse effects
- Treatment Outcome
- United States
- Valine -- adverse effects
- Valsartan
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.